Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

CUSIP: 15673T100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,670,044
Total 13F shares
16,881,896
Share change
+16,881,896
Total reported value
$490,834,435
Price per share
$29.34
Number of holders
35
Value change
+$490,834,432
Number of buys
35

Quarterly Holders Quick Answers

What is CUSIP 15673T100?
CUSIP 15673T100 identifies IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2021

As of 30 Jun 2021, Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,881,896 shares. The largest 10 holders included FMR LLC, Casdin Capital, LLC, SB Management Ltd, Avidity Partners Management LP, Logos Global Management LP, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., FEDERATED HERMES, INC., ORBIMED ADVISORS LLC, and Octagon Capital Advisors LP. This page lists 35 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.